US Patent 11787803 Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
Patent 11787803 was granted and assigned to FORMA Therapeutics on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+555 characters)
US Patent 11787803 Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
Article
Patent abstract
The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains, and methods of synthesis of these compounds.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Angela V. West
Anna Ericsson
Bradford Graves
Hongbin Li
Jennifer R. Downing
Shawn E. R. Schiller
Steven Mischke
Torsten Herbertz
Date of Patent
October 17, 2023
Patent Application Number
17669135
Date Filed
February 10, 2022
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11787803 Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
